IVF denied as experimental or investigational by Cigna?

Cigna's specific coverage criteria for IVF are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Denied Your IVF as Experimental or Investigational

Cigna may classify a service as "experimental or investigational" when it determines there is insufficient evidence of clinical effectiveness or when the service falls outside what Cigna considers established medical practice. For IVF itself — a decades-old, widely practiced procedure — this denial most commonly applies to specific add-on procedures or adjunctive treatments performed alongside or during an IVF cycle rather than to IVF as a whole. Examples might include certain embryo testing modalities or novel laboratory protocols. Occasionally, however, standard IVF is denied under this category in error.

## Why This Denial Is Appealable

IVF as a core procedure is recognized as standard of care by leading reproductive medicine organizations. If Cigna is applying an "experimental" label to standard IVF, that classification contradicts broad clinical consensus and should be challenged with medical literature support. If the denial targets a specific adjunctive technology, your physician can provide evidence-based justification for its use and document why it is clinically necessary for your case. Cigna's own coverage policy must cite specific clinical criteria for the experimental designation — you are entitled to that documentation.

## Federal Appeal Framework

• Internal appeal: File under ERISA §503 or applicable state law within the deadline on your denial letter. Request the exact clinical evidence criteria and the specific Cigna coverage policy or clinical policy bulletin used to make the experimental determination.
• External review: Under ACA §2719, experimental/investigational denials are specifically subject to mandatory independent external review. File within four months of the final internal denial. IROs assess whether the clinical evidence supports the experimental classification.
• Expedited review: Available when your physician certifies that delay poses a serious health risk given your fertility timeline.

## Documentation to Gather

• Diagnosis and clinical indication: Full records establishing the medical basis for IVF and, if applicable, the specific adjunctive procedure that was denied.
• Published clinical evidence: Your physician should identify peer-reviewed support for the procedure from recognized reproductive medicine organizations — without citing specific trial names or statistics, reference the relevant guideline organization (e.g., the applicable ASRM guideline) for support.
• Medical-necessity letter: A detailed letter from your reproductive endocrinologist explaining why the procedure is standard of care for your clinical situation and not experimental.
• Cigna clinical policy bulletin: Request the specific bulletin Cigna used; evaluate whether your case meets criteria that should qualify as covered.

## Criteria-Mapping Structure

Obtain Cigna's clinical policy bulletin for the denied service. List each criterion Cigna uses to define "experimental." For each criterion, document the clinical evidence or chart fact that contradicts that characterization as applied to your case. Your physician's letter should mirror this structure and cite the applicable guideline organization. A systematic rebuttal that addresses Cigna's own language is most likely to succeed at both internal and external review.